Whoa. You took the words right out of my mouth.I was just about...

Whoa. You took the words right out of my mouth.
I was just about to post this..

Initially P3 CHF results were supposed to be released 1st Qtr 2020.
Then it was delayed to the fuzzier 'Mid Year'.
But once we hit August, it would more accurate to say 3rd Qtr 2020.

So if the results are not released early next week I will consider this a second delay.

I can accept that timelines don't always go to plan. Some things are out of Mesoblast control, sometimes other work takes priority and resources away. But if the company is going to be late with results, the very least they can do is inform the market and maybe give an indication as to why. It's not much to ask. Investor communications has always been a weakness and it's frustrating. They need to lift their game in this area - it's not difficult.

Speaking of investor relations - has @vinn posted recently? ( my search function is down).
I'd be keen to hear an update of his views on when we can expect results and his confidence in the upcoming trials. Not casting aspersions mind you..just interested.